These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2904647

  • 21. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
    Marsh JD, Smith TW.
    Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y, Jakobs KH.
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [Abstract] [Full Text] [Related]

  • 23. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
    Karkanias GB, Etgen AM.
    Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
    [Abstract] [Full Text] [Related]

  • 24. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
    Lenox RH, Ellis J, Van Riper D, Ehrlich YH.
    Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
    [Abstract] [Full Text] [Related]

  • 25. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
    De Léan A, Ong H, Gutkowska J, Schiller PW, McNicoll N.
    Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
    [Abstract] [Full Text] [Related]

  • 26. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
    Stickle D, Barber R.
    Mol Pharmacol; 1993 Mar; 43(3):397-411. PubMed ID: 8095693
    [Abstract] [Full Text] [Related]

  • 27. Membrane reconstitution of high-affinity alpha 2 adrenergic agonist binding with guanine nucleotide regulatory proteins.
    Kim MH, Neubig RR.
    Biochemistry; 1987 Jun 16; 26(12):3664-72. PubMed ID: 2888480
    [Abstract] [Full Text] [Related]

  • 28. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
    Yabaluri N, Medzihradsky F.
    Mol Pharmacol; 1995 Oct 16; 48(4):690-5. PubMed ID: 7476895
    [Abstract] [Full Text] [Related]

  • 29. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
    Hoyer D, Reynolds EE, Molinoff PB.
    Mol Pharmacol; 1984 Mar 16; 25(2):209-18. PubMed ID: 6142414
    [Abstract] [Full Text] [Related]

  • 30. The ligand-receptor-G-protein ternary complex as a GTP-synthase. steady-state proton pumping and dose-response relationships for beta -adrenoceptors.
    Broadley KJ, Nederkoorn PH, Timmerman H, Timms D, Davies RH.
    J Theor Biol; 2000 Jul 21; 205(2):297-320. PubMed ID: 10873440
    [Abstract] [Full Text] [Related]

  • 31. Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding.
    Chamberlain J, Offord SJ, Wolfe BB, Tyau LS, Wang HL, Frazer A.
    J Pharmacol Exp Ther; 1993 Aug 21; 266(2):618-25. PubMed ID: 8355195
    [Abstract] [Full Text] [Related]

  • 32. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S, Nunn C, Zupanc GK, Hoyer D.
    Auton Autacoid Pharmacol; 2005 Jan 21; 25(1):1-16. PubMed ID: 15659149
    [Abstract] [Full Text] [Related]

  • 33. Alpha 1-adrenergic receptor-linked guanine nucleotide-binding protein in muscle and kidney epithelial cells.
    Terman BI, Slivka SR, Hughes RJ, Insel PA.
    Mol Pharmacol; 1987 Jan 21; 31(1):12-20. PubMed ID: 3027523
    [Abstract] [Full Text] [Related]

  • 34. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
    Convents A, De Backer JP, Convents D, Vauquelin G.
    Mol Pharmacol; 1987 Jul 21; 32(1):65-72. PubMed ID: 2885739
    [Abstract] [Full Text] [Related]

  • 35. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM, Harden TK.
    J Pharmacol Exp Ther; 1984 Feb 21; 228(2):425-33. PubMed ID: 6319678
    [Abstract] [Full Text] [Related]

  • 36. p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors.
    Baron BM, Siegel BW.
    Mol Pharmacol; 1990 Sep 21; 38(3):348-56. PubMed ID: 1976227
    [Abstract] [Full Text] [Related]

  • 37. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
    Macfarlane DE, Stump DC.
    Mol Pharmacol; 1982 Nov 21; 22(3):574-9. PubMed ID: 6296652
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM, Hess HJ, Grodski A, Graham RM, Homcy CJ.
    Mol Pharmacol; 1986 Mar 21; 29(3):219-27. PubMed ID: 3005829
    [Abstract] [Full Text] [Related]

  • 39. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors.
    Contreras ML, Wolfe BB, Molinoff PB.
    J Pharmacol Exp Ther; 1986 Apr 21; 237(1):165-72. PubMed ID: 2870175
    [Abstract] [Full Text] [Related]

  • 40. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
    Tian WN, Duzic E, Lanier SM, Deth RC.
    Mol Pharmacol; 1994 Mar 21; 45(3):524-31. PubMed ID: 8145737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.